PROGRESS IN IDENTIFYING BINDERS TO DISEASE-RELEVANT TAU AND α-SYNUCLEIN WITH THERAPEUTIC OR DIAGNOSTIC POTENTIAL

ADVERTISEMENT RETURN TO BOOKPREVChapterNEXTPROGRESS IN IDENTIFYING BINDERS TO DISEASE-RELEVANT TAU AND α-SYNUCLEIN WITH THERAPEUTIC OR DIAGNOSTIC POTENTIALAndrew G. CapacciAndrew G. CapacciInstitute for Neurodegenerative Diseases, University of California San Francisco, San Francisco, California, U.S.A.More by Andrew G. Capacci and Nick A. ParasNick A. ParasInstitute for Neurodegenerative Diseases, University of California San Francisco, San Francisco, California, U.S.A.More by Nick A. ParasDOI: 10.1021/mc-2024-vol59.ch02Publication Date (Web):November 18, 2024Publication HistoryPublished online18 November 2024Request reuse permissions Copyright © 2024 MEDI, Inc. Published by American Chemical Society.2024 Medicinal Chemistry ReviewsChapter 2pp 15-35Medicinal Chemistry ReviewsVol. 59ISBN13: 9781734427493eISBN: 9781734427486Chapter Views-Citations-LEARN ABOUT THESE METRICSChapter Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts. Share ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookXWeChatLinkedInRedditEmail Other access options Get e-Alerts